Jianying Zhang

Dr. Jianying Zhang

Xiangya School of Stomatology, Central South University, Changsha , Hunan, PR China
+1
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2021 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
JCJéssica Alves de Cena
Jéssica Alves de Cena
Jianying ZhangJianying Zhang
Jianying Zhang
DDDongmei Deng
Dongmei Deng
NDNaile Dame-Teixeira
Naile Dame-Teixeira
TDThuy Do
Thuy Do
Research on the human microbiome has mainly been restricted to the identification of most abundant microbiota associated with health or disease. Their abundance may reflect their capacity to exploit their niche, however, metabolic functions exerted by low-abundant microrganisms can impact the dysbiotic signature of local microbial habitats. This scoping review aims to map the literature regarding the management of low-abundant microorganisms in studies investigating human microbiome samples. A systematic literature search was performed in 5 electronic databases, as well as grey literature. We selected clinical microbiome studies targeting human participants of any age, from any body site. We also included studies with secondary data which originated from human biofilm samples. All of the papers used next-generation sequencing (NGS) techniques in their methodology. A total of 826 manuscripts were retrieved, of which 42 were included in this review and 22 reported low-abundant bacteria (LB) in samples taken from 7 body sites (breast, gut, oral cavity, skin, stomach, upper respiratory tract (URT), and vagina). Four studies reported microbes at abundance levels between 5 and 20%, 8 studies reported between 1 and 5%, and 18 studies reported below 1%. Fifteen papers mentioned fungi and/or archaea, and from those only 4 (fungi) and 2 (archaea) produced data regarding the abundance of these domains. While most studies were directed towards describing the taxonomy, diversity and abundance of the highly abundant species, low-abundant species have largely been overlooked. Indeed, most studies select a cut-off value at <1% for low-abundant organisms to be excluded in their analyses. This practice may compromise the true diversity and influence of all members of the human microbiota. Despite their low abundance and signature in biofilms, they may generate important markers contributing to dysbiosis, in a sort of ‘butterfly effect’. A detailed snapshot of the physiological, biological mechanisms at play, including virulence determinants in the context of a dysbiotic community, may help better understand the health-disease transition.

31 October 2025 in Nature Aging
Verified
Journal Article
Closed access
PDF file
EFEvandro Fang
Evandro Fang
YFYuan Fang
Yuan Fang
GCGuobing Chen
Guobing Chen
He-Ling WangHe-Ling Wang
He-Ling Wang
Jianying ZhangJianying Zhang
Jianying Zhang
HZHuachun Zou
Huachun Zou

9 September 2025 in Nature Aging
Verified
Journal Article
Closed access
PDF file
Jianying ZhangJianying Zhang
Jianying Zhang
He-Ling WangHe-Ling Wang
He-Ling Wang
Sofie LautrupSofie Lautrup
Sofie Lautrup
HNHilde Loge Nilsen
Hilde Loge Nilsen
JTJonas Thue Treebak
Jonas Thue Treebak
EFEvandro Fang
Evandro Fang

Verified
Journal Article
Open access
PDF file
He-Ling WangHe-Ling Wang
He-Ling Wang
Sofie LautrupSofie Lautrup
Sofie Lautrup
DCDOMENICA CAPONIO
DOMENICA CAPONIO
Jianying ZhangJianying Zhang
Jianying Zhang
EFEvandro F. Fang
Evandro F. Fang
DNA repair ensures genomic stability to achieve healthy ageing, including cognitive maintenance. Mutations on genes encoding key DNA repair proteins can lead to diseases with accelerated ageing phenotypes. Some of these diseases are xeroderma pigmentosum group A (XPA, caused by mutation of XPA), Cockayne syndrome group A and group B (CSA, CSB, and are caused by mutations of CSA and CSB, respectively), ataxia-telangiectasia (A-T, caused by mutation of ATM), and Werner syndrome (WS, with most cases caused by mutations in WRN). Except for WS, a common trait of the aforementioned progerias is neurodegeneration. Evidence from studies using animal models and patient tissues suggests that the associated DNA repair deficiencies lead to depletion of cellular nicotinamide adenine dinucleotide (NAD+), resulting in impaired mitophagy, accumulation of damaged mitochondria, metabolic derailment, energy deprivation, and finally leading to neuronal dysfunction and loss. Intriguingly, these features are also observed in Alzheimer’s disease (AD), the most common type of dementia affecting more than 50 million individuals worldwide. Further studies on the mechanisms of the DNA repair deficient premature ageing diseases will help to unveil the mystery of ageing and may provide novel therapeutic strategies for AD.

1 May 2016 in Microbiological Research
Verified
Journal Article
Closed access
Jianying ZhangJianying Zhang
Jianying Zhang
JLJia Liu
Jia Liu
JLJunqi Ling
Junqi Ling
ZTZhongchun Tong
Zhongchun Tong
YFYun Fu
Yun Fu
MLMin Liang
Min Liang

14 May 2026 in Nature Aging
Verified
Journal Article
Open access
JPJun-Ping Pan
Jun-Ping Pan
PWPing-Jie Wang
Ping-Jie Wang
Jianying ZhangJianying Zhang
Jianying Zhang
AKAnne-Brita Knapskog
Anne-Brita Knapskog
LWLeiv Otto Watne
Leiv Otto Watne
EFEvandro Fang
Evandro Fang
ULK1 (Atg1) initiates macroautophagy and mitophagy, which support neuronal growth and survival, yet how this pathway is disrupted in aging and Alzheimer's disease (AD) remains unclear. Here we report reduced ULK1 in serum and cerebrospinal fluid during aging in cognitively unimpaired participants from the COGNORM study (n = 75) and in patients with AD from the NorCog Memory Clinic Cohort (n = 316). In AD mice, ULK1 overexpression stimulates autophagic flux, reduces AD pathology and delays cognitive decline alongside increased phagocytic degradation of amyloid-β, reduced tauopathy and improved mitochondrial quality. Mechanistically, ULK1 upregulation increases autophagy and PINK1-, FUNDC1- and AMBRA1-associated mitophagy; higher autophagy and mitophagy increase cellular NAD+, which in turn deacetylates acetylated-Tau174 via the NAD+-SIRT1 axis, leading to reduced tauopathy. Using in vitro tau seeding assays and a Caenorhabditis elegans tau model, we validate the efficacy of ULK1 activators in inhibiting tauopathy. We propose that age-related decline in ULK1 leads to autophagy and mitophagy impairment and increases the progression of AD and identify ULK1 as a potential therapeutic target.